{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T19:31:50Z","timestamp":1782329510600,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","e-jmii.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jmii.2015.06.009","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T18:50:45Z","timestamp":1439578245000},"page":"924-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in\u00a0vitro synergy tests"],"prefix":"10.1016","volume":"49","author":[{"given":"Shio-Shin","family":"Jean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Chin","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Wan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Sen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Jen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2015.06.009_bib1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society; Infectious Diseases Society of America","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2015.06.009_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/cid\/ciq154","article-title":"Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia","volume":"52","author":"Chuang","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2015.06.009_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jinf.2010.07.002","article-title":"Clinical manifestations, antimicrobial therapy, and prognostic factors of monomicrobial Acinetobacter baumannii complex bacteremia","volume":"61","author":"Lee","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2015.06.009_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jmii.2013.07.005","article-title":"Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan","volume":"48","author":"Ku","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2015.06.009_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijantimicag.2013.02.001","volume":"41","author":"Jean","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2015.06.009_bib6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jac\/dkh080","article-title":"In\u00a0vitro and in\u00a0vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain","volume":"53","author":"Ko","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2015.06.009_bib7","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3201\/eid0805.020014","article-title":"Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan","volume":"8","author":"Hsueh","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jmii.2015.06.009_bib8","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/AAC.01330-10","article-title":"Penetration of meropenem into epithelial lining fluid of patients with ventilator-associated pneumonia","volume":"55","author":"Lodise","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.06.009_bib9","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1128\/AAC.01559-10","article-title":"Meropenem penetration into epithelial lining fluid in mice and humans and delineation of exposure targets","volume":"55","author":"Drusano","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.06.009_bib10","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1592\/phco.27.11.1506","article-title":"Combination carbapenem\u2013sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in\u00a0vitro combination synergy study","volume":"27","author":"Lee","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jmii.2015.06.009_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/00365540510026869","article-title":"Treatment of pan-drug resistant Acinetobacter baumannii","volume":"37","author":"Lee","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jmii.2015.06.009_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jac\/dki477","article-title":"In\u00a0vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis","volume":"57","author":"Petersen","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2015.06.009_bib13","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/AAC.40.8.1914","article-title":"Comparison of three different in\u00a0vitro methods of detecting synergy: time-kill, checkerboard, and E test","volume":"40","author":"White","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.06.009_bib14","series-title":"Hospital epidemiology and infection control","first-page":"1659","article-title":"Surveillance of nosocomial infections","author":"Horan","year":"2004"},{"key":"10.1016\/j.jmii.2015.06.009_bib15","series-title":"FDA drug safety communication: Increased risk of death of tygacil (tigecycline) compared to other antibiotics to treat similar infections","author":"FDA","year":"2010"},{"key":"10.1016\/j.jmii.2015.06.009_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jmii.2015.06.009_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00003246-198108000-00008","article-title":"APACHE\u2013acute physiology and chronic health evaluation: a physiology based classification system","volume":"9","author":"Knaus","year":"1981","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jmii.2015.06.009_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2015.06.009_bib19","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1121","article-title":"Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic \u201cblind\u201d bronchoalveolar lavage fluid","volume":"143","author":"Pugin","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jmii.2015.06.009_bib20","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.jmii.2015.06.009_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(67)90168-7","article-title":"Acute respiratory distress in adults","volume":"2","author":"Ashbaugh","year":"1967","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2015.06.009_bib22","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jama.1994.03510440058033","article-title":"Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality","volume":"271","author":"Pittet","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jmii.2015.06.009_bib23","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/JCM.01798-07","article-title":"Application of a microsphere-based array for rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities","volume":"46","author":"Lin","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2015.06.009_bib24","series-title":"Performance standards for antimicrobial susceptibility testing; Twenty-third informational supplement","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2013"},{"key":"10.1016\/j.jmii.2015.06.009_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1128\/JCM.01588-06","article-title":"Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp","volume":"45","author":"Jones","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2015.06.009_bib26","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1128\/JCM.43.7.3129-3135.2005","article-title":"Detection of Pseudomonas aeruginosa producing metallo-\u03b2-lactamase in a large centralized laboratory","volume":"43","author":"Pitout","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2015.06.009_bib27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jmii.2013.03.008","article-title":"Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan","volume":"47","author":"Chuang","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2015.06.009_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.diagmicrobio.2011.03.003","article-title":"Comparative in\u00a0vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU","volume":"70","author":"Sheng","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2015.06.009_bib29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2165\/00003495-200767070-00006","article-title":"Comparative review of the carbapenems","volume":"67","author":"Zhanel","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.jmii.2015.06.009_bib30","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","article-title":"Pharmacokinetic issues for antibiotics in the critically ill patient","volume":"37","author":"Roberts","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jmii.2015.06.009_bib31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/JCM.33.3.551-555.1995","article-title":"Pulse-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus","volume":"33","author":"Bannerman","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2015.06.009_bib32","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1128\/AAC.49.8.3198-3202.2005","article-title":"Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii","volume":"49","author":"H\u00e9ritier","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.06.009_bib33","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10096-013-1870-4","article-title":"Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections","volume":"32","author":"Lee","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2015.06.009_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijantimicag.2009.01.015","article-title":"Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint","volume":"34","author":"Burkhardt","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2015.06.009_bib35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.diagmicrobio.2010.05.012","article-title":"Comparison of tigecycline with imipenem\/cilastatin for the treatment of hospital-acquired pneumonia","volume":"68","author":"Freire","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2015.06.009_bib36","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/AAC.01615-10","article-title":"Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline","volume":"56","author":"Bhavnani","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.06.009_bib37","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1128\/AAC.01232-12","article-title":"Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem\u2013cilastatin for treatment of hospital-acquired pneumonia","volume":"57","author":"Ramirez","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.06.009_bib38","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1086\/653057","article-title":"Pharmacokinetic\u2013pharmacodynamic considerations in the design of hospital-acquired or ventilator-associated bacterial pneumonia studies: look before you leap!","volume":"51","author":"Ambrose","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2015.06.009_bib39","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1128\/AAC.00497-10","article-title":"Synergy testing by E test, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii","volume":"54","author":"Sopirala","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.06.009_bib40","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1592\/phco.27.7.980","article-title":"Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii","volume":"27","author":"Schafer","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jmii.2015.06.009_bib41","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jmii.2011.01.033","article-title":"Microbial isolation and emergence of antimicrobial resistance associated with tigecycline usage","volume":"44","author":"Chen","year":"2011","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2015.06.009_bib42","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1128\/AAC.40.3.677","article-title":"Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa","volume":"40","author":"Cappelletty","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.06.009_bib43","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1517\/14656566.2011.599320","article-title":"Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens","volume":"12","author":"Jean","year":"2011","journal-title":"Expert Opin Pharmacother"}],"updated-by":[{"DOI":"10.1016\/j.jmii.2017.01.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000}}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118215008191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118215008191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T06:29:57Z","timestamp":1599460197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118215008191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1684118215008191"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2015.06.009","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jmii.2017.01.002","asserted-by":"object"}]},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in\u00a0vitro synergy tests","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2015.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}